Welcome to LookChem.com Sign In|Join Free
  • or
2-Chloromethyloxazole is a chemical compound that belongs to the class of aromatic heterocyclic compounds, characterized by the presence of a heteroatom in a planar system, which confers aromaticity. It has a molecular formula of C4H4ClNO and is relatively stable, although it should be stored in a cool, dry place to maintain its properties. Currently, the compound is primarily utilized for research purposes, and there is limited information available regarding its toxicity or ecological impact.

185246-17-7

Post Buying Request

185246-17-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

185246-17-7 Usage

Uses

Used in Research Applications:
2-Chloromethyloxazole is used as a research chemical for the investigation of its properties and potential applications in various scientific fields. Its aromatic heterocyclic nature makes it a valuable compound for studying the effects of heteroatoms on the aromaticity and stability of organic compounds. Additionally, it may be employed in the synthesis of more complex molecules or as a building block in the development of new materials or pharmaceuticals.

Check Digit Verification of cas no

The CAS Registry Mumber 185246-17-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,5,2,4 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 185246-17:
(8*1)+(7*8)+(6*5)+(5*2)+(4*4)+(3*6)+(2*1)+(1*7)=147
147 % 10 = 7
So 185246-17-7 is a valid CAS Registry Number.
InChI:InChI=1/C4H4ClNO/c5-3-4-6-1-2-7-4/h1-2H,3H2

185246-17-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(chloromethyl)-1,3-oxazole

1.2 Other means of identification

Product number -
Other names 2-chloromethyl-oxazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:185246-17-7 SDS

185246-17-7Relevant academic research and scientific papers

Preparation method of 2-oxazolylmethylamine heterocyclic compound

-

Paragraph 0025; 0027; 0030; 0032, (2020/02/14)

The invention relates to a preparation method of a 2-oxazolylmethylamine heterocyclic compound. The preparation method comprises the following steps: reacting 1H-1,2,3-triazole with chloroacetyl chloride under the action of DIPEA, and carrying out heating for conversion into 2-chloromethyloxazole; adding a product of the previous step into a reaction system of di-tert-butyl iminodicarboxylate andsodium hydride in batches to form 2-[(di-tert-butyloxycarbonylamino)methyl]oxazole; and dissolving 2-[(di-tert-butyloxycarbonylamino)methyl]oxazole in a methanol solution of hydrogen chloride, carrying out concentration after a complete of reaction, adding methyl tert-butyl ether, and performing filtering and drying to obtain the 2-oxazolylmethylamine heterocyclic compound. The invention providesan effective process route for preparing the 2-oxazolylmethylamine heterocyclic compound.

ANTI-BACTERIAL COMPOUNDS

-

Page/Page column 101, (2017/06/28)

A compound of Formula (II): for use in the prevention or treatment of a bacterial infection.

HETEROCYCLIC GTP CYCLOHYDROLASE 1 INHIBITORS FOR THE TREATMENT OF PAIN

-

Page/Page column 46, (2011/04/19)

The present invention relates to the field of small molecule heterocyclic inhibitors of GTP cyclohydrolase (GCH-I), or a tautomer, prodrug, or pharmaceutically acceptable salt thereof. The invention also features pharmaceutical compositions of the compounds and the medical use of these compounds for the treatment or prevention of pain (e.g., inflammatory pain, nociceptive pain, functional pain, or neuropathic pain).

4- (IH-INDAZOL-S-YL-AMINO)-QUINAZOLINE COMPOUNDS AS ERBB RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER

-

Page/Page column 93, (2008/06/13)

A quinazoline derivative of the Formula I: wherein the substituents are as defined in the text for use in the production of an anti proliferative effect which effect is produced alone or in part by inhibiting erbB2 receptor tyrosine kinase in a warm blood

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 185246-17-7